## Abstract To evaluate the fraction of invasive cervical carcinoma (ICC) that could be prevented in HIV‐infected women by vaccines currently available against human papillomavirus (HPV)16 and 18, we conducted a cross‐sectional study in women with ICC in Nairobi, Kenya. Fifty‐one HIV‐positive women
Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa
✍ Scribed by Dianne J. Marais; Jo-Ann S. Passmore; Lynette Denny; Candice Sampson; Bruce R. Allan; Anna-Lise Williamson
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 97 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
This study tested cervical and oral human papillomavirus (HPV) infection in HIV‐1 seropositive (HIV+) and seronegative (HIV−) women to determine any association between infections at both sites and the difference in prevalence of the HPV types infecting these women. Participants were 115 women referred to a colposcopy clinic after diagnosis of abnormal cervical cytology. The women showed low grade cervical intraepithelial neoplasia (CIN1) or high grade disease (CIN2/3) or no CIN based on colposcopy and histology. Typing of HPV in cervical and oral cells was by Roche linear array and included direct sequencing on selected oral samples. Cervical HPV prevalence was 86.5% and 97.1% in HIV− and HIV+ women respectively. With the exception of HPV‐45, prominent in HIV+ women, the hierarchy of predominant types were similar in HIV− and HIV+ women. HPV‐16 was most prevalent in both HIV+ (41.7%) and HIV− women (38.5%) with CIN2/3. Significantly more HIV+ women had multiple cervical (>1) infections than HIV− women (36.1% vs. 88.2%, P < 0.001) and more oral HPV infections (45.5% and 25% respectively; P = 0.04). The most prevalent oral HPV types were HPV‐33, ‐11, and ‐72. The majority of women did not have concordant oral and cervical HPV types, reflecting possible independence of infection at the two sites. HIV immune suppression did not impact significantly on the predominant types of cervical HPV infection (except for HPV‐45). HIV+ women had more multiple HPV infections and those with severe cervical disease a similar prevalence of HIV‐16 but a lower HPV‐18 prevalence than HIV− women. J. Med. Virol. 80:953–959, 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Human papillomavirus (HPV) infection is associated with almost all cases of cervical cancer, and cervical cancer is a common malignancy in women living in developing countries. A cross‐sectional study was conducted to determine the prevalence of HPV infection, human immunodeficiency vir
## Abstract Human papillomavirus type 16 (HPV‐16) classes (E, AA, As, Af1, Af2) and their variants have different geographic distribution and different degrees of association with cervical lesions. This study was designed to examine HPV‐16 variants among Italian women and their prevalence in case p
This study investigated the relationship between human papillomavirus type 16 (HPV-16) antibodies detected in oral fluid from women with cervical neoplasia, their HPV-16 antibody seroprevalence, and their cervical HPV-16 DNA presence. Cervical HPV-16 DNA was detected by polymerase chain reaction in
## Abstract Oncogenic human papillomaviruses (HPVs) are obligate mucosal pathogens and typically cause localized infections. The mucosal surface of the genital tract also provides the first line of defense against genital HPV infection. Although local antibody production following HPV‐infection has
a significant role in the development of cervical intra-Sera from 95 women with cervical intraepithelial epithelial neoplasia (CIN) and cervical cancer [Schiffneoplasia (CIN), 95 age-matched female blood man, 1992]. South Africa has an extremely high incidonors, and 155 children aged between 1 and 1